In addition to its primary use as a tumor marker for CRC [19, 20], elevated serum carcinoembryonic antigen (CEA) level has also been implicated in various other cancers including breast [21, 22], lung [23], and gastric [24, 25] cancers. This evidence concerns the gene CEACAM5 and neoplasm.